| Market Capitalization (Millions $) |
368,831 |
| Shares
Outstanding (Millions) |
2,721 |
| Employees |
126,500 |
| Revenues (TTM) (Millions $) |
80,684 |
| Net Income (TTM) (Millions $) |
1,372 |
| Cash Flow (TTM) (Millions $) |
4,971 |
| Capital Exp. (TTM) (Millions $) |
3,563 |
Johnson & Johnson
Johnson & Johnson, is engaged in the manufacture and sale of a broad range
of products in the health care field. Through over 200 operating companies, it
conducts business in virtually all countries of the world. Johnson & Johnson's
primary interest, both historically and currently, has been in products related
to human health and well-being. Johnson & Johnson was organized in the State
of New Jersey in 1887.
| JNJ is expected to report next financial results on October 15, 2018. |
Next quarterly dividend payout on September 10, 2018. |
|
3.06 %
0.6% 